789 related articles for article (PubMed ID: 23416119)
1. Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions.
Klaassen I; Van Noorden CJ; Schlingemann RO
Prog Retin Eye Res; 2013 May; 34():19-48. PubMed ID: 23416119
[TBL] [Abstract][Full Text] [Related]
2. [Pathogenesis of diabetic macular oedema].
Krohne TU; Fauser S; Kirchhof B; Joussen AM
Klin Monbl Augenheilkd; 2003 Aug; 220(8):521-5. PubMed ID: 12953153
[TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of blood-retinal barrier loss in the Akimba mouse, a model of advanced diabetic retinopathy.
Wisniewska-Kruk J; Klaassen I; Vogels IM; Magno AL; Lai CM; Van Noorden CJ; Schlingemann RO; Rakoczy EP
Exp Eye Res; 2014 May; 122():123-31. PubMed ID: 24703908
[TBL] [Abstract][Full Text] [Related]
4. The Blood-Retinal Barrier in the Management of Retinal Disease: EURETINA Award Lecture.
Cunha-Vaz J
Ophthalmologica; 2017; 237(1):1-10. PubMed ID: 28152535
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of Retinal Fluid Accumulation and Blood-Retinal Barrier Breakdown.
Cunha-Vaz J
Dev Ophthalmol; 2017; 58():11-20. PubMed ID: 28351041
[TBL] [Abstract][Full Text] [Related]
6. Pathophysiology of macular edema.
Scholl S; Kirchhof J; Augustin AJ
Ophthalmologica; 2010; 224 Suppl 1():8-15. PubMed ID: 20714176
[TBL] [Abstract][Full Text] [Related]
7. Electron microscopic immunocytochemical evidence for the mechanism of blood-retinal barrier breakdown in galactosemic rats and its association with aldose reductase expression and inhibition.
Vinores SA; Van Niel E; Swerdloff JL; Campochiaro PA
Exp Eye Res; 1993 Dec; 57(6):723-35. PubMed ID: 8150024
[TBL] [Abstract][Full Text] [Related]
8. Blood-retinal barrier.
Cunha-Vaz J; Bernardes R; Lobo C
Eur J Ophthalmol; 2011; 21 Suppl 6():S3-9. PubMed ID: 23264323
[TBL] [Abstract][Full Text] [Related]
9. A novel co-culture model of the blood-retinal barrier based on primary retinal endothelial cells, pericytes and astrocytes.
Wisniewska-Kruk J; Hoeben KA; Vogels IM; Gaillard PJ; Van Noorden CJ; Schlingemann RO; Klaassen I
Exp Eye Res; 2012 Mar; 96(1):181-90. PubMed ID: 22200486
[TBL] [Abstract][Full Text] [Related]
10. The role of plasmalemma vesicle-associated protein in pathological breakdown of blood-brain and blood-retinal barriers: potential novel therapeutic target for cerebral edema and diabetic macular edema.
Bosma EK; van Noorden CJF; Schlingemann RO; Klaassen I
Fluids Barriers CNS; 2018 Sep; 15(1):24. PubMed ID: 30231925
[TBL] [Abstract][Full Text] [Related]
11. Altered expression of genes related to blood-retina barrier disruption in streptozotocin-induced diabetes.
Klaassen I; Hughes JM; Vogels IM; Schalkwijk CG; Van Noorden CJ; Schlingemann RO
Exp Eye Res; 2009 Jun; 89(1):4-15. PubMed ID: 19284967
[TBL] [Abstract][Full Text] [Related]
12. Diabetic macular edema: passive and active transport of fluorescein through the blood-retina barrier.
Sander B; Larsen M; Moldow B; Lund-Andersen H
Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):433-8. PubMed ID: 11157879
[TBL] [Abstract][Full Text] [Related]
13. Protective factors in diabetic retinopathy: focus on blood-retinal barrier.
Zhang C; Wang H; Nie J; Wang F
Discov Med; 2014 Sep; 18(98):105-12. PubMed ID: 25227751
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of protein kinase C decreases prostaglandin-induced breakdown of the blood-retinal barrier.
Saishin Y; Saishin Y; Takahashi K; Melia M; Vinores SA; Campochiaro PA
J Cell Physiol; 2003 May; 195(2):210-9. PubMed ID: 12652648
[TBL] [Abstract][Full Text] [Related]
15. Plasmalemma Vesicle-Associated Protein Has a Key Role in Blood-Retinal Barrier Loss.
Wisniewska-Kruk J; van der Wijk AE; van Veen HA; Gorgels TG; Vogels IM; Versteeg D; Van Noorden CJ; Schlingemann RO; Klaassen I
Am J Pathol; 2016 Apr; 186(4):1044-54. PubMed ID: 26878208
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiology of diabetic macular edema.
Joussen AM; Smyth N; Niessen C
Dev Ophthalmol; 2007; 39():1-12. PubMed ID: 17245075
[TBL] [Abstract][Full Text] [Related]
17. The inner blood-retinal barrier: Cellular basis and development.
Díaz-Coránguez M; Ramos C; Antonetti DA
Vision Res; 2017 Oct; 139():123-137. PubMed ID: 28619516
[TBL] [Abstract][Full Text] [Related]
18. Decursin inhibits VEGF-mediated inner blood-retinal barrier breakdown by suppression of VEGFR-2 activation.
Kim JH; Kim JH; Lee YM; Ahn EM; Kim KW; Yu YS
J Cereb Blood Flow Metab; 2009 Sep; 29(9):1559-67. PubMed ID: 19536074
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of vitreoretinal VEGF elevation and blood-retinal barrier breakdown in streptozotocin-induced diabetic rats by brimonidine.
Kusari J; Zhou SX; Padillo E; Clarke KG; Gil DW
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1044-51. PubMed ID: 19710406
[TBL] [Abstract][Full Text] [Related]
20. The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas.
Murata T; Nakagawa K; Khalil A; Ishibashi T; Inomata H; Sueishi K
Lab Invest; 1996 Apr; 74(4):819-25. PubMed ID: 8606491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
